Home Healthcare Biotechnology Gene Expression Market

Gene Expression Market Size, Share & Trends Analysis Report By Process (Sample Collection, Purification, cDNA Synthesis and Conversion, PCR Analysis, Data Analysis and Interpretation), By Product (Kits and Reagents, DNA Chips), By Capacity (Low- to Mid- Plex, High-Plex), By Technique (RNA Expression, Promoter Analysis, Protein Expression and Posttranslational Modification Analysis), By Applications (Drug Discovery and Development, Clinical Diagnostics, Biotech and Microbiology) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Gene Expression Market Size

The global gene expression market size was valued at USD 15.89 billion in 2025 and is projected to grow from USD 16.66 billion in 2026 to USD 24.38 billion by 2034, registering a CAGR of 4.87% during the forecast period from 2026 to 2034. North America dominated the gene expression market with a market share of 38.5% in 2025.

The increasing demand for personalized therapy and targeted therapeutics is a significant driver of growth in the gene expression industry.

Gene expression is a portion of the life sciences and biotechnology industries that focuses on analyzing and measuring gene expression patterns within cells and organisms. Gene expression is the process through which information contained in genes is used to produce functional gene products, such as proteins or RNA molecules, that have an essential role in a variety of biological processes. The gene expression market includes diverse technologies, goods, and services for studying and quantifying gene expression levels and patterns.

Gene Expression Market Size

Download a Free Sample To learn more about this report.

Product Insights

The market is segmented into kits and reagents, DNA chips, and others. The kits and reagents segment dominates the global market and is expected to expand substantially over the forecast period. This important form of the foundation of molecular biology and genetic research, providing scientists and researchers with the core instruments required for a wide range of experiments. Kits and reagents include a wide range of goods designed for a variety of purposes, such as DNA amplification, gene expression analysis, PCR (polymerase chain reaction), and others. Their versatility and broad utility make them indispensable in laboratories and research institutes worldwide. Researchers rely largely on these pre-packaged kits and reagents for consistency and convenience, and this segment's long-standing position in the market cements its dominance.

"DNA Chips" or microarrays are the fastest-growing gene expression analysis market segment. These advanced techniques have gained growing interest and use in recent years because of their ability to undertake high-throughput investigations of gene expression and genetic variants. DNA chips are important in genomics, personalized medicine, and pharmaceutical research because they allow researchers to observe the expression groups of thousands of genes simultaneously or analyze DNA sequences thoroughly. Technological developments in microarray technology, such as the development of whole-genome and single-cell arrays, are driving the segment's rapid expansion.

Gene Expression Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The market is divided into drug discovery and development, clinical diagnostics, biotech and microbiology, and others. The drug discovery and development segment is the highest contributor to the market and is estimated to grow significantly over the forecast period. This section has a lengthy history due to its significance in pharmaceutical research and development. Understanding gene expression in healthy and pathological conditions is critical for discovering possible medication targets, developing drug candidates, and evaluating treatment success. In addition, gene expression analysis is an essential tool in drug development, making this area a market leader. The demand for gene expression analysis in drug discovery and development remains steady as genomics advances and the continuous pursuit of novel medicines continues.

Clinical diagnostics has grown dramatically due to the increased use of gene expression analyses in healthcare settings. Gene expression profiling is used in clinical diagnostics to identify illness biomarkers, aid in early disease identification, and guide tailored therapy decisions.

Gene Expression Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global gene expression market shareholder and is expected to grow significantly over the forecast period. The United States, in particular, has established itself as a powerhouse in gene expression analysis. The cornerstone for this leadership is a rich and advanced research infrastructure comprised of famous research institutes, world-class universities, and cutting-edge research hospitals. These institutions have consistently conducted groundbreaking gene expression studies that have pushed the bounds of scientific discovery. Furthermore, North America is home to some of the most important corporations in the biotechnology and pharmaceutical industries. These companies stimulate innovation and shape the gene expression landscape by inventing cutting-edge technologies and setting industry standards. The region also benefits from significant biomedical research funding, with institutions such as the National Institutes of Health (NIH) supporting advances in genomics and gene expression analyses. This integrated ecosystem establishes North America, particularly the United States, as a global gene expression business market leader.

North America Gene Expression Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Gene Expression Market Trends

The Asia-Pacific region has witnessed notable growth in the gene expression industry in recent years. With countries like China and India included, the Asia-Pacific region is the one that is expanding the fastest in the gene expression industry. The region is leading the way in gene expression analysis, and a strong convergence of these factors supports its growth. Notable investments have markedly improved research capacities in biotechnology infrastructure, healthcare capabilities, and life sciences research. The region's prominence has been reinforced by the boom in gene expression studies that have resulted from these investments. Moreover, the Asia-Pacific area frequently offers financial benefits for research projects, drawing international biotechnology and pharmaceutical firms looking for effective and affordable research solutions. The need for gene expression analysis has increased due to the emphasis on precision medicine and personalized healthcare in nations like China and India, especially for clinical diagnosis and tailored treatment choices.

In addition, Asia-Pacific, driven by China and India, is rising quickly and maintaining its position as the fastest-growing global market thanks to a strong biotechnology sector and a dedication to furthering genomics research. It is imperative to recognize that market dynamics are dynamic, and the forces that dictate dominance and expansion might shift. Therefore, keeping up to date with the most recent industry evaluations and market research reports is essential for gaining a thorough grasp of the geographical dynamics of the global market.

List of Key and Emerging Players in Gene Expression Market

Catalent Inc.
QIAGEN
Quest Diagnostics Inc.
Hoffmann-La Roche Ltd.
Illumina Inc.
PerkinElmer Inc.
Bio-Rad Laboratories
Thermo Fisher Scientific Inc.
Agilent Technologies
GE Healthcare

Key Industry Developments

June 2026
Merck KGaA agreed to acquire Bio-Techne for approximately USD 11.3 billion, strengthening its life science portfolio in advanced biological research, gene expression analysis tools, cell and gene therapy, and precision diagnostics.
March 2026
Bio-Rad Laboratories launched the SEQuoia Express Stranded RNA Library Prep Kit, enabling faster and more efficient RNA sequencing library preparation for gene expression research and transcriptomics applications.
February 2026
QIAGEN expanded its QIAcuity digital PCR portfolio with new assays and workflow enhancements to improve highly sensitive gene expression analysis and biomarker research.
January 2026
Thermo Fisher Scientific introduced new transcriptomics and gene expression workflow solutions for next-generation sequencing and single-cell analysis, expanding its genomic research portfolio.

Report Scope

Segmentation

By Process 5
  • Sample Collection
  • Purification
  • cDNA Synthesis and Conversion
  • PCR Analysis
  • Data Analysis and Interpretation
By Product 2
  • Kits and Reagents
  • DNA Chips
By Capacity 2
  • Low- to Mid- Plex
  • High-Plex
By Technique 3
  • RNA Expression
  • Promoter Analysis
  • Protein Expression and Posttranslational Modification Analysis
By Applications 3
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Biotech and Microbiology

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Catalent Inc. · QIAGEN · Quest Diagnostics Inc. · Hoffmann-La Roche Ltd. · Illumina Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The gene expression market size is valued at USD 16.66 Billion in 2026 and is projected to reach USD 24.38 Billion by 2034, at a CAGR of 4.87% during the forecast period 2026-2034.

North America dominated the market with a share of 38.5% in 2025.

The leading players in this market are Catalent Inc., QIAGEN, Quest Diagnostics Inc., Hoffmann-La Roche Ltd., Illumina Inc..

The gene expression market is projected to grow at a CAGR of 4.87% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: